Spleen cells analyzed by ELISPOT for IFNγ secretion, using immunodominant MAA peptides of tyrosinase and gp100, were found to include a much higher proportion of tumor specific T cells in tumor bearing mice treated with α-gal glycolipids than in mice with tumors injected with PBS [53]. The gene discussed is TYR; the disease is neoplasm.